Shifting Trends In Marketing Approvals Of Orphan Drugs
After stalling the week prior, the U.S. House of Representatives passed the Fairness in Orphan Drug Exclusivity Act on May 19 with an overwhelming majority....To view the full article, register now.
Already a subscriber? Click here to view full article